BACKGROUND: Black women are more likely to experience adverse effects from cancer treatment such as lymphedema. Thus, black women may particularly benefit from research regarding interventions to improve lymphedema. Herein, the authors report the challenges and strategies related to the recruitment of minority survivors of breast cancer and to the recruitment of survivors of breast cancer with lymphedema into the Women In Steady Exercise Research (WISER) Survivor Clinical Trial. METHODS: Subjects for this community-based trial were recruited from the Philadelphia area through active (mailings) and passive (printed materials and Web site) recruitment strategies. In addition, education sessions coordinated through partner hospitals in communities with a predominantly minority population were conducted to increase awareness of lymphedema in survivors of breast cancer. Women who were interested in the study were screened for lymphedema via telephone questionnaire and invited to see a study-related certified lymphedema therapist to confirm the presence of lymphedema. RESULTS: Screening was conducted among 2295 women: 628 were eligible, 450 consented, and 351 were randomized. Minority women comprised 38% of the study population. Letters to women on state and hospital registries resulted in a 0.4% randomization rate; education sessions yielded a 10% randomization rate. The authors observed that approximately 23.6% of the study sample had no previous diagnosis of lymphedema. CONCLUSIONS: The WISER Survivor Clinical Trial faced multiple recruitment challenges and used unique strategies to successfully enroll minority survivors of breast cancer into a lifestyle intervention. Cancer 2018;124:95-104.
INTRODUCTION
Breast cancer is the most commonly diagnosed cancer in women and accounts for approximately 41% of all female cancers. 1 Although black women historically are less likely than white women to be diagnosed with breast cancer, breast cancer-specific mortality rates remain higher among black compared with white women. 2, 3 Furthermore, black women are more likely to experience common adverse effects of cancer treatment, 4, 5 including breast cancer-related lymphedema (BCRL). [6] [7] [8] [9] Finally, knowledge regarding lymphedema varies across the population of survivors of breast cancer, with low educational level and black race found to be predictive of lower awareness of this chronic condition. 10 As such, black women may particularly benefit from research regarding interventions to improve lymphedema and breast cancer recurrence risk, but may be less likely to know that they have the condition.
Minorities in general are underrepresented in medical research. 11, 12 There are multiple reasons minorities have been underrepresented in intervention studies. 12, 13 For example, in the black community, there is a long documented history of a distrust of research and the health care system. 13, 14 Research that includes a sufficient number of ethnic minority cancer survivor populations is crucial to addressing the disparities in health outcomes observed across race, ethnicity, and socioeconomic status. 15 Such research also is crucial to understanding how treatment may need to change to meet the unique needs of these populations, 16 yet to the best of our knowledge such research is scarce. Therefore, it is of vital importance to recruit a diverse sample when studying issues relevant to lymphedema and breast cancer recurrence. To fill this gap, the Women In Steady Exercise Research (WISER) Survivor Clinical Trial had a specific goal to recruit at least 35% black women into the study.
We designed a randomized controlled trial to test hypotheses regarding the effects of exercise and/or weight loss on lymphedema outcomes and risk of disease recurrence. To the best of our knowledge, prior large exercise and weight loss studies of survivors of breast cancer have included few black women (range, 1.2%-10.2%). [17] [18] [19] [20] The goal of the current study was to share successes and challenges in recruiting an ethnically diverse cohort of survivors of breast cancer with BCRL.
MATERIALS AND METHODS

Overview
Major concerns for recruitment into the current trial were multifold. First, when studying BCRL, challenges include a lack of public awareness and underdiagnosis of the condition. 21, 22 Second, there is a need to ensure that those who participate in research on this condition are broadly representative of the target population. Third, the trial required repeated in-person attendance at weekly meetings for approximately 75% of study participants. Geographic and travel considerations had to be considered to ensure that participants received the interventions as prescribed. This resulted in the use of a community-based approach in conjunction with hospital partnerships. [23] [24] [25] Given these challenges, we developed multiple unique strategies with which to complete recruitment, as described herein.
Study Design
Survivors of breast cancer who were at least 6 months posttreatment were randomized into 4 equal-sized groups: 1) no intervention; 2) an exercise program alone; 3) a weight loss program alone; or 4) the combination of weight loss and exercise programs. All 4 groups received 2 lymphedema compression garments and ongoing lymphedema care paid for by grant funds. All activities were reviewed and conducted in accordance with the University of Pennsylvania's Institutional Review Board. All participants provided written informed consent before participating in any study activities.
The current study is registered at ClinicalTrials.gov (identifier NCT01515124).
The WISER Survivor Clinical Trial interventions took place in hospital cancer centers, community-based health facilities, and YMCAs. The recruiter, project manager, and principal investigator met with primary hospital stakeholders (cancer center staff, physicians, administrative personnel, lymphedema specialists, nurses, and nutritionists) to develop partnerships. It took 6 months to 8 months to solidify partnerships, obtain regulatory approvals, and identify administrative staff before mailing recruitment letters from an individual hospital tumor registry. Hospitals received National Institutes of Health research credits for their institution for each participant enrolled in the study.
The exercise intervention included twice-weekly strength training for 1 year, with the first 6 weeks supervised by certified fitness professionals. The 1-year weight loss intervention consisted of weekly small group meetings with a registered dietitian for behavioral counseling for the first 6 months. During the latter 6 months, groups met once per month. Participants used a food replacement system for the first 5 months (Nutrisystem Inc, Fort Washington, PA) and were weaned onto conventional grocery shopping for the remainder of the year. Participants in the combined intervention group attended both the exercise sessions and weight loss sessions on the same schedule as described above. Eligibility criteria are outlined in Table 1 .
Recruitment Strategies
Intervention locations were chosen based on the density of survivors residing within the zip code of the fitness center or hospital (as determined by state cancer registry data) as well as interest and ability of the facilities to assist with the trial (eg, available staff to reserve room space, sufficient space to conduct interventions, Institutional Review Board approval). With few exceptions, participants lived within a 20-minute drive of the facility at which they participated in the exercise intervention. Recruitment took place in waves, according to the geographic location of the participating centers. Active, passive, and combined recruitment methods were used for the current study.
Active recruitment
Active recruitment refers to activities in which researchers initiate direct contact. These approaches have been shown to be successful in prior trials. 25, 26 Letters were mailed in batches (waves) corresponding to zip codes surrounding a specific intervention site. The goal of this approach was to target women who lived closest to the intervention facility proposed for that recruitment wave and ensure that Original Article distance to the intervention site was not an additional barrier to participation. 27 We mailed letters to survivors of breast cancer identified by the Pennsylvania and New Jersey state cancer registries. State registries have been shown to be helpful tools with which to find eligible participants, and are an unbiased source of participants for populationbased studies. 26, 28 Some partnering hospitals also mailed recruitment letters. When this occurred, the hospitalbased letters were mailed on hospital letterhead and signed by a prominent physician from that medical center. Finally, we also mailed letters to women who were ineligible for prior trials conducted by the research team.
Passive recruitment
Passive recruitment included the participation of WISER Survivor Clinical Trial staff and interns in 2 community events, and the distribution of print and broadcast media. The study also maintained a Web site to which women could be referred.
Combined active/passive recruitment
The general underdiagnosis of lymphedema in survivors of breast cancer created a unique challenge for this recruitment effort. In an effort to overcome this challenge, we developed a new strategy to contact patient populations via letter and in person. The study team realized that creating an educational event for survivors of breast cancer could provide an effective opportunity to teach them about adverse effects of breast cancer, including lymphedema. Our hope was that this also would increase the rate of recruitment. We chose to pursue this, despite evidence that many of these additional outlets can be very costly, and yield very few participants. 16, 29, 30 The After Breast Cancer (ABC) Survivor Education sessions were conducted 12 times, in conjunction with several partnering hospitals. Each session took 2 to 3 hours and required 5 to 7 staff members. During these sessions, WISER Survivor Clinical Trial staff offered on-site, in-person health screenings regarding obesity (body mass index calculation), bone health (osteoporosis risk assessment instrument), 31 heart health (blood pressure assessment and national guidelines for risk level given results), 32 and lymphedema (Norman Lymphedema Survey). 33 The principal investigator gave a 1-hour presentation concerning common sequelae of breast cancer treatment covering evidence on causes, prevalence, timing, prevention, and treatment. The final slide briefly described the WISER Survivor Clinical Trial. Women were invited to ask questions if they were interested in study participation. These education sessions were open to the public and advertised by the hospitals. Women who were known to be ineligible to participate in the trial were welcomed to attend.
Efforts to Target Recruitment Toward Racial/Ethnic Minority Groups
We used multiple strategies to increase the participation of racial/ethnic minorities. The WISER Survivor Clinical Trial targeted ethnic minorities, specifically black women. Black women are more likely to develop BCRL, 8 and 2 ) Plans for additional (eg, curative or reconstructive) surgery during the study period Self-report of weight-lifting within the past y Already engaging in aerobic activity of moderate intensity 3 times per wk Planning to move away from the area over the next y Current use of weight loss medication (OTC or prescription) Self-report of alcohol or substance abuse within the past 12 mo, including at-risk drinking (current consumption of > 14 alcoholic drinks per wk) Weight loss > 10% of body weight within the past 3 mo Participants who develop a recurrence during the study will go off study (except for nonmelanoma skin cancers)
Abbreviations: BMI, body mass index; OTC, over the counter. a In cases of questionable eligibility regarding whether a potential participant had controlled lymphedema, a CLT evaluation was conducted. blacks are the largest racial/ethnic minority group in Philadelphia. Furthermore, overrecruitment of black women improves the ability to generalize findings to a broader cross-section of survivors. 26 To facilitate this goal, we partnered with hospitals in communities with a predominantly black population. Staff members were trained in understanding the issues of racism and ethnic inclusiveness in research. Study marketing materials included a wide representation of races, ages, body types, and ethnicities to reflect the diversity of participants to be recruited into the study. 16 The recruitment letter included a statement that "minority women are encouraged to apply." In addition, there was an effort to ensure that study staff was ethnically diverse.
RESULTS
WISER Survivor
Clinical Trial staff mailed a total of 69,266 letters for the study, including letters from the Pennsylvania Cancer Registry and the New Jersey State Cancer Registry, as well as hospital tumor registries (Fig.  1) . Two women in Pennsylvania and 1 woman in New Jersey responded negatively when contacted through the state cancer registries (<0.00004% and <0.00001%, respectively). A total of 24 individuals responded to report deaths beyond what the state registry already excluded before providing the mailing list. Finally, 29 letters were mailed to women who were ineligible for prior studies by the research team. The response rates (defined as a telephone inquiry regarding the study) were 3.6% for state registries, 3.9% for hospital registries, and 79.3% for the women from prior studies. Of the 69,237 women who received a state or hospital registry letter, 280 were randomized into the study, netting a response rate of 0.4%. By contrast, of the 29 women who were sent a letter based on their being deemed ineligible for a prior trial, 9 were randomized into the study, netting a response rate of 31.0%.
Recruitment lasted 39 months. We obtained informed consent from 2 to 3 participants per week, which required the effort of 1 full-time staff member. Figure 1 depicts recruitment, screening, randomization, and retention for the study. Figure 1 also shows the number of cancer recurrences and participants who were dropped from the study at 6 months and 12 months of follow-up. The primary results for the WISER Survivor Clinical Trial will be reported in 2018. Figure 2 provides a map of sites, as well as sample size per site, by wave. By the end of recruitment, 5 fitness centers and 10 hospitals participated, for a total of 15 recruitment waves. Table 2 provides an overview of the recruitment source for all 351 randomized participants, overall and by race. The New Jersey and Pennsylvania cancer registries provided the study with the most randomized participants (52.7%). Letters sent from hospitals netted approximately 20.2% of randomized participants. There was no significant association noted between the method of recruitment and the reported race of the participant.
More than 130 women attended the ABC Survivor Education sessions. Of these, 32.0% of the women consented and 26.9% were randomized. These women comprised nearly 10% of the randomized participants in the current study.
There were 121 women who answered yes to telephone screening questions regarding lymphedema symptoms but had no prior diagnosis. Of these 121 women, 102 were determined to have lymphedema based on a standardized clinical evaluation by a certified lymphedema therapist. 34 Subsequently, 95 women consented and 83 were randomized. This indicates that 23.6% of the current study sample had no previous diagnosis of lymphedema. Furthermore, of the 121 women who did not know they had lymphedema, 84.0% were diagnosed by a study certified lymphedema therapist. Table 3 shows the age and race for the 843 women who progressed far enough in the screening process for these metrics to be obtained. There were no significant differences noted in the distribution of age during the recruitment process. There was a trend (P 5 .07) toward black women having greater interest early in the recruitment process (scheduling a consent session). Table 4 provides a demographic description of the 351 women who were randomized into the WISER Survivor Clinical Trial stratified by race. Figure 3 provides a comparison of the age distributions of the 2 state cancer registries and the women randomized into the trial, as well as a comparison of the race distributions. Original Article
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DISCUSSION
The WISER Survivor Clinical Trial successfully recruited 351 survivors of breast cancer with lymphedema and achieved the goal of recruiting >35% of black women for the study sample (127 women). At randomization, approximately 38% of the study sample self-reported being an ethnic minority (133 women). This cohort of 127 black survivors of breast cancer is equal in size to the Women's Intervention Nutrition Study trial, which also included 127 black women. 18 Our success in recruiting a diverse sample for the WISER Survivor Clinical Trial arises from lessons learned from previous studies regarding the efficient, effective recruitment of participants. 25, 29, 30, 35 The approaches outlined in the current study demonstrate that efficient, focused recruitment strategies can result in success in recruiting a diverse cohort of cancer survivors, even within the context of limited resources. Key components of our successful recruitment include diversity and cultural appropriateness of the study staff, tracking the results of multiple recruitment methods and abandoning those with low yield, the inclusion of active and passive recruitment approaches, and partnering with community organizations and hospitals to make it geographically easier for women to participate.
The use of state cancer registries and hospital tumor registries was an effective means of recruiting, regardless of race, because 76% of randomized participants reported hearing about the trial through these sources. That said, with only 1 recruiter on staff, the volume of calls received each time 1000 to 6000 letters were mailed was a staffing challenge. It quickly became clear that the speed with which we followed up was crucial to consenting and randomizing eligible participants. The leading reason women did not consent was because they stopped responding to our telephone calls.
In addition, establishing relationships with local hospitals and community organizations proved to be a time-consuming administrative effort. Hospital partnerships took at least 6 months from the initial e-mail and presentation by the study team to the culminating signing ceremony that served as a contractual relationship between the study and the institution. Relationships established from previous studies were instrumental in establishing sites expediently. Two incentives were offered to hospitals for collaboration: 1) the ability to register patients enrolled for research credits and 2) the opportunity to train hospital staff to deliver an evidence-based rehabilitative exercise program for survivors of breast cancer. 36 Only 3 partners took advantage of this offer for training. A financial incentive for the primary staff involved could help to improve the consistent communication needed to take on the administrative tasks required (eg, regulatory approvals, identifying patients, and mailings). Future studies may benefit from budgeting for monetary compensation of the hospital staff. Those seeking to use the approach described herein are advised to establish these relationships before recruitment to limit the amount of coordination during the study.
The findings of the current study further confirm the need for direct contact with participants via a letter or face to face with a study representative. In the WISER Survivor Clinical Trial recruitment effort, the least costly and most effective recruitment approach was the ABC Survivor Education sessions. This was a novel approach stemming from the observation that our recruitment was affected adversely by the lack of patient knowledge regarding BCRL. Given that 10% of the women randomized attended 1 of these sessions, we would recommend this patient education session approach to recruitment in situations in which the goal is to recruit patients with an underdiagnosed condition.
The results of the current study demonstrated the feasibility of recruiting a diverse group of survivors of breast cancer into a randomized controlled trial of diet and exercise interventions. Future studies should consider the use of cancer registries. In addition, connections with local hospital programs to engage support groups through education may be effective for boosting recruitment. The data and experiences shared will inform the recruitment of multiethnic and geographically diverse groups of cancer survivors for future research. Better representation of target populations in clinical research studies leads to more persuasive study results, and will enable providers to shape the care of survivors of breast cancer in a manner relevant to those of all ethnicities and backgrounds.
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